Vistagen Therapeutics (VTGN) Return on Assets [ROA] (2012 - 2026)
Vistagen Therapeutics (VTGN) recorded Return on Assets [ROA] of -160.48% in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 87.69 percentage points from -72.79% a year earlier and down 37.78 percentage points from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Return on Assets [ROA] (2012 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Vistagen Therapeutics reported Return on Assets [ROA] of -104.90%, down 55.46 percentage points from FY2025.
- Annual Return on Assets [ROA] has a five-year change of -73.45 percentage points (FY2021 to FY2026).
- Across earlier fiscal years, Return on Assets [ROA] came in at -49.44% in FY2025 (-8.87 pp), -40.57% in FY2024 (+83.21 pp), -123.78% in FY2023 (-71.56 pp) and -52.22% in FY2022 (-20.77 pp).
- The fiscal Q1 2027 figure is the lowest quarterly Return on Assets [ROA] since fiscal Q1 2024.
- On a year-over-year basis, Return on Assets [ROA] has declined for seven consecutive quarters, with an average year-over-year change of -30.76 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 228.78 percentage points in fiscal Q1 2025, against a drop of 175.44 percentage points in fiscal Q4 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at -122.70% (Q4 2026), -91.85% (Q3 2026) and -83.06% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Vistagen Therapeutics | 12.43 Mn | 12.43 Mn | - | -160.48% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -160.48% |
| Mar 31, 2026 | -122.70% |
| Dec 31, 2025 | -91.85% |
| Sep 30, 2025 | -83.06% |
| Jun 30, 2025 | -72.79% |
| Mar 31, 2025 | -58.22% |
| Dec 31, 2024 | -48.57% |
| Sep 30, 2024 | -36.63% |
| Jun 30, 2024 | -27.99% |
| Mar 31, 2024 | -23.05% |
| Dec 31, 2023 | -37.02% |
| Sep 30, 2023 | -123.99% |
| Jun 30, 2023 | -256.77% |
| Mar 31, 2023 | -233.27% |
| Dec 31, 2022 | -180.96% |
| Sep 30, 2022 | -129.71% |
| Jun 30, 2022 | -89.67% |
| Mar 31, 2022 | -57.83% |
| Dec 31, 2021 | -39.03% |
| Sep 30, 2021 | -31.36% |
API Access
Vistagen Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();